Natasha TardifManaging Partner- Paris at ReedSmithSpeaker
Profile
Natasha is Managing Partner of Reed Smith’s Paris office and co-leads its European Competition and Regulatory department. A British and French national, she is admitted in both jurisdictions and has practiced in New York, Paris, and London.
Natasha focuses on EU and French competition law, regulatory enforcement, and complex litigation, with an emphasis on the pharmaceutical and life sciences sectors. She regularly advises global pharmaceutical and healthcare companies on antitrust risk, distribution and market access strategies, pricing practices, parallel trade, compliance programmes, dawn raids, and investigations before the European Commission and the French Competition Authority.
She has developed particular knowledge of litigation, notably unfair competition cases, unfair trading rules, and more generally, commercial litigation.
Natasha regularly secures significant reductions of fines imposed by enforcement agencies as well as the annulment of investigation measures. She intervened in one of the rare cases of obstruction alleged by competition authorities, and obtained before the French Constitutional Council the unconstitutionality – and therefore the abrogation – of a French legal provision sanctioning obstruction.
Natasha is a lecturer at Paris and Abu Dhabi Sorbonne University, Queen Mary University, Seton Hall University School of Law, INSEAD, the University of Paris Cité, Paris II Assas, and Paris-Dauphine. She also regularly publishes articles in relation to her experience in various business sectors, gives interviews, and is often invited to speak at international conferences in the United States, London, Brussels, and Paris.
Natasha was awarded the International Bar Association’s Outstanding International Woman Lawyer Award for 2024. The prestigious award recognises those who have demonstrated excellence in their field and have influenced other women to pursue legal careers. She was also ranked in INvolve's Heroes Executive Role Model list in 2025.
Agenda Sessions
The Practical Application of EU and International Competition Principles to Pharmaceutical Markets
14:40View Session
